FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental hepatology, and can be used for simulating non-alcoholic fatty liver dystrophy for subsequent development of new therapeutic approaches to correction of this pathology. Method for simulating comprises thyroidectomy in rats, then, keeping animals in the vivarium at standard nutrition for the following 8 weeks. At the end of said period progression of non-alcoholic fatty dystrophy and signs of steatohepatitis and steato-fibrosis are being diagnosed.
EFFECT: method provides reliable quickly repeatable, maximally close to the clinical course of the disease model with minimum cost of experiment.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE | 2019 |
|
RU2728418C1 |
| METHOD OF SIMULATING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2015 |
|
RU2598351C1 |
| METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
| ANTYSTEATOSIS AGENT | 2019 |
|
RU2702003C1 |
| METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
| METHOD OF TREATING STEATOHEPATOSIS IN EXPERIMENTAL ANIMALS | 2023 |
|
RU2811886C1 |
| USING LACTITOL AND AN ORAL DOSAGE FORM FOR TREATING AND PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE | 2018 |
|
RU2692243C1 |
| METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
| MEANS FOR NON-ALCOHOLIC FATTY LIVER DISEASE TREATMENT AND PREVENTION | 2016 |
|
RU2644282C2 |
| METHOD FOR MODELING FATTY LIVER DISEASE OF MIXED GENESIS IN RATS | 2020 |
|
RU2757199C1 |
